DataMeds AI MEDS Cash Flow Statement (2024-2026)

NASDAQ MEDS
$1.45 +0.02 (+1.40%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.08M-0.57M-1.87M-4.33M-32.43M-6.67M-34.32M-27.85M-7.74M
Depreciation and Depletion (Quarter) 0.03M0.04M0.04M0.04M0.04M0.04M0.03M
Share-based Compensation (Quarter) 27.77M0.94M25.72M-9.17M1.36M
Asset Writedowns and Impairment (Quarter) 0.03M0.07M0.08M0.12M0.07M0.66M0.09M
Cash from Operations (Quarter) 0.03M0.33M1.04M-2.62M-1.35M-2.08M-1.14M-6.29M-3.41M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.43M0.61M0.76M0.76M0.76M0.76M0.33M
Depreciation & Amortization (CF) (Quarter) 0.03M0.04M0.04M0.04M0.04M0.04M0.03M
Change in Working Capital
Change in Receivables (Quarter) 0.04M0.00M0.18M-0.54M-1.00M0.56M-0.05M
Change in Inventory (Quarter) 0.38M-0.29M0.21M-0.70M-1.54M0.14M0.07M
Change in Account Payables (Quarter) 0.08M-0.29M-0.27M-0.41M1.88M1.27M0.96M-1.91M1.47M
Change in Accured Expenses (Quarter) -0.03M0.31M0.75M0.54M0.47M0.67M1.15M0.94M0.09M
Other Working Capital Changes (Quarter) 0.59M0.02M
Investing Activities
Acquisitions (Quarter) 0.90M
Cash from Investing Activities (Quarter) -0.32M0.80M-0.27M-0.13M-0.22M-0.26M-0.21M
Financing Activities
Other financing activities (Quarter) 4.00M
Cash from Financing Activities (Quarter) 0.26M-0.54M0.00M2.06M3.11M0.11M5.17M2.36M3.63M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 0.01M
Additional items
Change in Cash (Quarter) 0.29M-0.23M0.73M0.24M1.49M-2.10M3.81M-4.19M0.01M
Free Cash Flow (Quarter) 0.03M0.33M1.04M-2.62M-1.35M-2.08M-1.14M-6.29M-3.41M
Net Cash Flow (Quarter) 0.29M-0.21M0.73M0.24M1.49M-2.10M3.81M-4.19M0.01M